115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)
  7. Center for Hematologic Malignancies (13263)
  8. Hematologic Malignancies, Division of (13087)
  9. Sloan Kettering Institute Postdocs (12936)
  10. Department of Pathology and Laboratory Medicine (12615)
Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early identification and treatment of occult metastatic disease in stage III colon cancer (SU2C ACT3 clinical trial)
    Meeting Abstract

    Pappas, L.; Yaeger, R.; Kasi, P. M.; Shah, M. A.; Azad, N. S.; Horick, N. K.; Corcoran, R. B.; Diaz, L. A.; Parikh, A. R.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 1b study of sotorasib combined with panitumumab as second-line treatment of KRAS G12C-mutated colorectal cancer
    Meeting Abstract

    Yaeger, R.; Langer, C. J.; Ruffinelli, J. C.; Fakih, M.; Furqan, M.; Machiels, J. P. H.; Saportas, Y.; Nolte-Hippenmeyer, J.; Chan, E.; Xia, C.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Updated efficacy and safety of larotrectinib (laro) in patients (pts) with TRK fusion gastrointestinal (GI) cancer
    Meeting Abstract

    Shen, L.; Andre, T.; Chung, H. C. C.; Deeken, J. F.; Garralda, E.; Italiano, A.; Leyvraz, S.; Liu, T.; Burcoveanu, D. I.; Grugel, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • An online rectal cancer tumoroid biorepository: A resource to facilitate multimodal data integration
    Meeting Abstract

    Alvarez, J.; Zambare, W.; Wu, C.; Bleu, P.; Bercz, A.; Satravada, B.; Kundra, R.; De Bruijn, I.; Schultz, N.; Shia, J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of LY3537982, a potent and highly selective KRAS G12C inhibitor in KRAS G12C-mutant GI cancers: Results from a phase 1 study
    Meeting Abstract

    Hollebecque, A.; Kuboki, Y.; Murciano-Goroff, Y. R.; Yaeger, R.; Cassier, P. A.; Heist, R. S.; Fujiwara, Y.; Deming, D. A.; Ammakkanavar, N.; Patnaik, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Intrahepatic cholangiocarcinoma: Recurrence patterns, genomics and survival
    Meeting Abstract

    Chandra, P.; Song, Y.; Drill, E. N.; Wei, A. C. C.; Kemeny, N. E.; Cercek, A.; Connell, L. C.; Harding, J. J.; Abou-Alfa, G. K.; Park, W.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Diagnostic performance of endoscopy and MRI in identifying true response among patients with rectal cancer treated with total neoadjuvant therapy and selective watch and wait or TME
    Meeting Abstract

    Omer, D. M. R.; Williams, H.; Lin, S. T.; Thompson, H. M.; Verheij, F. S.; Yuval, J. B.; Buckley, J. T.; Qin, L. X.; Gollub, M. J.; Garcia-Aguilar, J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of patients with metastatic colitis-associated cancer treated with EGFR inhibitors
    Meeting Abstract

    Yeh, C.; Cowley, C.; Srivastava, A.; Chatila, W. K.; Ismailgeci, D.; Chou, J. F.; Capanu, M.; Shah, M. A.; Sanchez-Vega, F.; Ganesh, K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Local excision to enhance organ preservation in rectal cancer after favorable response to total neoadjuvant therapy
    Meeting Abstract

    Bercz, A.; Rosen, R.; Drescher, M.; Gonen, M.; Shia, J.; Nishimura, M.; Romesser, P. B.; Crane, C. H.; Saltz, L. B.; Cercek, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Enhancing patient selection for salvage radical prostatectomy: A new riskstratification model from a large retrospective cohort
    Meeting Abstract

    Calleris, G.; Marra, G.; Benfant, N.; Rajwa, P.; Ahmed, M.; Ghoreifi, A.; Abreu, A.; Ribeiro, L.; Westhofen, T.; Tourinho-Barbosa, R.; more...
    European Urology (2024)

    Fulltext@MSK | Save